REDUCED SEROLOGICAL RESPONSE TO COVID-19 BOOSTER VACCINES IN PATIENTS WITH IBD IS FURTHER DIMINISHED BY TNF INHIBITOR THERAPY; VARIATION STUDY PART 2 (VARIABILITY INRESPONSEIN IBDAGAINSTSARS-COV-2IMMUNISATION)

Jayne Doherty  1     Neil O┬┤Morain  2     Roisin Stack  2     Miriam Tosetto  2     Rosanna Inzitari  3     Elizabeth Ryan  4     David J. Daghfal  5     Peter Doran  3     Colm O'Morain  6     Glen A Doherty  3    
1 St Vincent's Hospital, Dublin, Ireland
2 St. Vincent's University Hospital, Dublin, Ireland
3 University College Dublin, Dublin, Ireland
4 University Limerick, Limerick, Ireland
5 Abbott Laboratories, Lake Forest, IL, United States
6 Trinity College Dublin - Faculty of Health Sciences, Trinity College Dublin, Dublin/IE, Dublin

Pathway
IBD, Neurogastroenterology & Motility, Nurses, Primary Care

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing